The Barcelona Institute for Global Health (ISGlobal) research team has developed the tools needed to definitively eradicate yaws from the planet: a diagnosis of yaws can now be confirmed using a new test based on a single drop of blood, and a single dose of azithromycin (an oral antibiotic) has been shown to be effective in curing the infection. http://www.who.int/yaws/photos/en/
The findings of the studies jump started the NTD community in action and prompted the World Health Organization (WHO) to target yaws for Global Eradication by 2020.
The objective of our new project is to evaluate the new WHO-strategy to stop yaws transmission which involves mass treatment with single dose oral azithromycin of the entire population. If the new strategy proves effective, countries will be free of the disease in one or two years after implementation.
What is the Ultimate Goal?
The goal is to eradicate yaws DEFINITIVELY WORLDWIDE in the short to medium term (10 years).
Yaws eradication will need a donation of 40 million treatments, with a cost of 0.50 Euro per treatment, and fundings to distribute the pill. Representatives of the countries where yaws is still endemic have made a commitment to fight this disease.
What is Yaws?
Yaws is a neglected disease that affects children and young adolescents aged between 1 and 15 years. Yaws, which is a close cousin to syphilis, causes large painful ulcers on the arms and legs. If left untreated, the bacteria may penetrate the patient's bone, often causing inflammation, pain and permanent disfigurement.
Documentary: War Against Yaws
The Broadcaster producer has started the filming of a documentary on Dr Oriol Mitjà's story: http://www.broadcaster.cat/pian
Newcrest Mining Limited
International SOS - Niugini
- Sergi Gavilán Project Assistant
Other projectsSee Past Projects
Combating Bacterial Resistance In Europe
Application to medical devices
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
Integrating and decentralizing diabetes and hypertension services in Africa
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission
Cendea de Cizur
Conèixer la propagació. Entendre la protecció
A breakthrough device for the rapid detection of antimicrobial resistance
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Hepatitis B Virus COMmunity Screening and Vaccination in Africans
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
Close the Gap, Increase Access, Provide Adequate Therapy